InhaleRx Limited (IRX.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 560.27 Thousand AUD | 0.0% |
| 2022 | - AUD | 0.0% |
| 2021 | - AUD | 0.0% |
| 2020 | - AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 318.61 Thousand AUD | -43.13% |
| 2024 Q2 | 318.61 Thousand AUD | 0.0% |
| 2023 FY | 560.27 Thousand AUD | 0.0% |
| 2023 Q1 | 92.01 Thousand AUD | 0.0% |
| 2023 Q2 | 92.01 Thousand AUD | 0.0% |
| 2023 Q3 | 560.27 Thousand AUD | 508.92% |
| 2023 Q4 | 560.27 Thousand AUD | 0.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 FY | - AUD | 0.0% |
| 2022 Q1 | - AUD | 0.0% |
| 2022 Q3 | - AUD | 0.0% |
| 2021 Q1 | - AUD | 0.0% |
| 2021 FY | - AUD | 0.0% |
| 2021 Q3 | - AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2020 Q3 | - AUD | 0.0% |
| 2020 FY | - AUD | 0.0% |
| 2020 Q4 | - AUD | 0.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2020 Q1 | - AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q1 | - AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2019 Q3 | - AUD | 0.0% |
| 2018 Q3 | - AUD | 0.0% |
| 2018 Q1 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q1 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q3 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 89.058% |
| Adherium Limited | 93.2 Thousand AUD | -501.121% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 91.781% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | -561.716% |
| Anteris Technologies Ltd | 2.33 Million AUD | 75.984% |
| Control Bionics Limited | 961.73 Thousand AUD | 41.743% |
| CardieX Limited | 3.22 Million AUD | 82.642% |
| Compumedics Limited | 6.97 Million AUD | 91.97% |
| Cochlear Limited | 243.7 Million AUD | 99.77% |
| CleanSpace Holdings Limited | 3.44 Million AUD | 83.743% |
| Cyclopharm Limited | 4.22 Million AUD | 86.746% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | 80.682% |
| Nova Eye Medical Limited | 3.34 Million AUD | 83.27% |
| HeraMED Limited | 260.65 Thousand AUD | -114.948% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 96.432% |
| ImpediMed Limited | 1.14 Million AUD | 50.982% |
| LBT Innovations Limited | 1.74 Million AUD | 67.856% |
| Micro-X Limited | 4.05 Million AUD | 86.183% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -692.782% |
| PolyNovo Limited | 15.38 Million AUD | 96.357% |
| Respiri Limited | 1.17 Million AUD | 52.38% |
| SomnoMed Limited | 1.01 Million AUD | 44.856% |
| Universal Biosensors, Inc. | 4.97 Million AUD | 88.73% |
| Uscom Limited | 989.27 Thousand AUD | 43.365% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | -79.486% |